GMP for Biopharmaceuticals

This Education Course concentrates on regulatory and practical requirements regarding biopharmaceutical production. From clinical phases to routine manufacturing practical examples and case studies will facilitate the implementation of GMP in your daily business.

The course will treat the topics of routine inspection from regulatory bodies and customers, quality assurance and quality control as well as in laboratory and production.

Speakers from manufacturing, laboratory, consultancy, and authority will show their expectations as well as their experiences in GMP implementation.

Background
Good Manufacturing Practice (GMP) is a fundamental regulatory framework designed to ensure that medicinal products are consistently produced and controlled according to quality standards. GMP plays a particularly critical role for biopharmaceuticals - therapeutics derived from living cells or biological processes - given their inherent complexity, variability and sensitivity compared to traditional small-molecule drugs.

Unlike chemically synthesised medicines, biopharmaceuticals such as monoclonal antibodies, recombinant proteins, vaccines and nucleic acid-based therapies are produced using living systems. This introduces unique challenges, including biological variability in raw materials, the susceptibility of production processes to subtle changes, and the risk of contamination by adventitious agents. GMP regulations mitigate these risks by requiring robust systems that safeguard product quality, safety, and efficacy throughout the manufacturing life cycle.

Regulatory authorities such as the U.S. Food and Drug Administration (FDA), the European Medicines Agency (EMA) and the International Council for Harmonisation (ICH) have established guidelines that set global expectations. For example, EMA Annex 2 addresses GMP specifically for biologics. Both industry and the authorities must prepare for new and anticipated changes in regulatory guidelines. Compliance with these guidelines is a legal requirement and a means of ensuring patient safety.

Ultimately, GMP in biopharmaceutical manufacturing ensures that complex biological products reach patients with the highest level of assurance regarding their safety, purity, and therapeutic effectiveness. GMP is the backbone of quality systems in the biopharmaceutical industry, balancing regulatory compliance with innovation to support the delivery of life-saving medicines worldwide.